4.15
-0.1(-2.35%)
Currency In GBp
Address
2545 West Hillcrest Drive
Thousand Oaks, CA 91320
United States of America
Phone
805-409-9868
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
8
First IPO Date
July 08, 2021
| Name | Title | Pay | Year Born |
| Dr. Paul Pagano Ph.D. | Chief Executive Officer, Chief Scientific Officer & Executive Director | 237,973 | 1985 |
| Mr. David Mark Anderson | Chief Financial Officer, Company Secretary & Executive Director | 179,497 | 1963 |
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
